-
Document de presse | 2023.12.05
COVID-19: the persistence of SARS-CoV-2 in the lungs and the role of innate immunity
One to two weeks after contracting COVID, the SARS-CoV-2 virus generally becomes undetectable in the upper respiratory tract. But does that mean that it is no longer present in the body? To find out, a team from the Institut Pasteur specialized in HIV, in collaboration with a French public research institute, the Alternative Energies and Atomic Energy Commission (CEA), conducted a study on lung...
-
News | 2023.12.11
Toscana virus causes unexplained encephalitis
A team from the Institut Pasteur in Paris, in collaboration with researchers in Spain, has identified Toscana virus in samples taken from patients in southern Spain. This virus is responsible for cases of encephalitis that have never been fully explained. The presence of this virus in the samples challenges the assumption that it was rare in the Mediterranean region. Thanks to this discovery,...
-
Document de presse | 2023.12.05
Improving the diagnosis of infection: a prospective study clarifies the role of an innovative metagenomic tool
Scientists from Necker-Enfants Malades Hospital (AP-HP), the Institut Pasteur, Université Paris Cité, Inserm, Université Paris-Est Créteil and the Alfort National Veterinary School, coordinated by Professor Marc Eloit and Dr. Anne Jamet in collaboration with Dr. Jacques Fourgeaud and Beatrice Regnault, studied the role of global genetic characterization of samples (or non-targeted metagenomics)...
-
Document de presse | 2023.12.14
Working together against deadly Marburg virus
International research consortium receives highly endowed Horizon Europe funding for the development of vaccines against Marburg viruses.The multidisciplinary European consortium MARVAX will receive 7.4 million euros over the next four years for the research and development of vaccines against Marburg viruses. Researchers from France, Spain and Germany will develop novel vaccine candidates, which...
-
News | 2023.12.19
Tick-borne viruses evade innate immunity
Flaviviruses are pathogens transmitted by ticks that can cause serious diseases including neurological disorders. A study conducted at the Institut Pasteur reveals how these viruses can slip between the cracks of immunity.
-
News | 2023.12.20
Hepatitis B: using mathematics to reveal the best treatment model in The Gambia
To accelerate momentum in the global fight against hepatitis B, expanding testing and treatment services in resource-limited countries is crucial, especially in sub-Saharan Africa. But determining which patients are eligible for treatment is a complex process and requires tests that are not widely accessible in these regions. Should all people infected with the virus be treated without assessing...
-
News | 2023.12.18
Climate and health: the latest on a silent epidemic
While the main outcome of COP28 was an agreement calling on the parties to "transition away from fossil fuels" with the aim of limiting climate change, it was also the first COP to include a Health Day. Rising global temperatures, extreme meteorological phenomena and ecosystem change are not merely environmental concerns. They are catalysts of a silent epidemic that is affecting human health....
-
News | 2024.01.05
The Institut Pasteur wishes you a happy new year 2024
The Institut Pasteur wishes you all the best, with a greetings card created with photographer Marguerite Bornhauser.
-
Document de presse | 2024.01.05
The Institut Pasteur and Sensorion announce that their partnership to accelerate gene therapy programs targeting hearing disorders has been extended for five years
The framework extension agreement underlines the successful collaboration between Sensorion and the Institut Pasteur, involving the Hearing Institute, a research center of the Institut Pasteur, focused on the development of gene therapy programs Two gene therapy development programs are currently being conducted under this agreement, including SENS-501 (OTOF-GT) and GJB2-GT. Sensorion submitted a...
-
Document de presse | 2024.01.11
Professor Yasmine Belkaid takes office as President of the Institut Pasteur
The Institut Pasteur is pleased to announce that Professor Yasmine Belkaid took office as its new President on January 2, 2024. Her appointment, approved by the Board of Governors on March 29, 2023, marks the beginning of a six-year term as President of the Institut Pasteur.Professor Yasmine Belkaid is a renowned scientist whose research focuses on the relationship between microbes and the immune...
